| (11) | Number of the document | 4894 |
| (21) | Number of the application | a 2023 0010 |
| (22) | Filing date of the application | 2023.05.19 |
| | Date of filing the request for examination | (de fond) 19.05.2023 |
| (71) | Name(s) of applicant(s), code of the country | INSTITUTIA PUBLICA UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (72) | Name(s) of inventor(s), code of the country | MACAEV Fliur, MD; KHRIPACH Vladimir, BY; STANGACI Eugenia, MD; ZHABINSKII Vladimir, BY; SUCMAN Natalia, MD; HRABAVETS Iryna, BY; BILAN Dmitrii, MD; TSYBRUK Tatsiana, BY; COJOCARI Sergiu, MD; |
| (73) | Name(s) of owner(s), code of the country | INSTITUTIA PUBLICA UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (54) | Title of the invention | 3-(2-((3S,10R,13S)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthrene-17-yl)-2-oxoethyl)-1-vinyl-1H-imidazol-3-ium chloride with antitumor activity against prostate cancer |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | C07J 43/00 (2006.01); A61K 31/58 (2006.01); A61P 35/00 (2006.01); |
| (19) | Country | MD |
| (45) | Date of publication of patent granting decision: | 2024.05.31 |
| (47) | Date of issuance of patent | 2024.12.31 |
| | Substantive examiner(s) | LEVIŢCHI Svetlana |
| | Payment for maintenance up to the date | 2028.05.19 |